EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieVergleichsstudieOpen Access

Comparison of 20% Autologous Platelet-Rich Plasma Versus Conventional Treatment in Moderate to Severe Dry Eye Patients

Shubhi Sachan iD, Kshama Dwivedi iD, Satya Prakash Singh iD, Santosh Kumar iD, Vinod Kumar Singh iD

Turkish Journal of Ophthalmology · 2025

DOI: 10.4274/tjo.galenos.2025.47717 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Turkish Journal of Ophthalmology, 2025. Verfasst von Shubhi Sachan und 4 weiteren Autor:innen. Beteiligte Einrichtung: Regional Institute of Ophthalmology, MLN Medical College, Department of Ophthalmology, Prayagraj, India. Hauptthemen laut MEDLINE: Platelet-Rich Plasma, Dry Eye Syndromes, Visual Acuity. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

To evaluate the effectiveness of conventional therapy and 20% autologous platelet-rich plasma (aPRP) eye drops for moderate to severe dry eye disease (DED). Materials and Methods: In this prospective interventional study, 40 individuals (80 eyes) with moderate to severe DED were analyzed. Twenty patients each were randomly assigned to the study and control groups. The study group was given 20% aPRP eye drops; the control group was given artificial tears as per conventional treatment. Comprehensive eye examinations including evaluation of best corrected visual acuity (BCVA), tear meniscus height, tear break-up time (TBUT), Schirmer's test, corneal fluorescein staining, conjunctival impression cytology, and Ocular Surface Disease Index (OSDI) were conducted in both groups for 3 months. Pre- and posttreatment results were compared.

Results

The average age of patients in the study group was 51±14 years (range, 37-65 years), whereas that of the control group was 50±17 years (range, 33-67 years). After 3 months, there was a more significant decrease in OSDI score in the study group than in the control group (p 0.05). Measurements of tear meniscus height, Schirmer's value, and TBUT at 3 months showed statistically significant differences (p 0,05). Üçüncü ayda gözyaşı menisküs yüksekliği, Schirmer değerleri ve GKZ’de istatistiksel olarak anlamlı farklılıklar izlendi (p

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Platelet-Rich PlasmaDry Eye SyndromesVisual AcuityHumansFemaleMaleMiddle AgedProspective StudiesAdultAgedTearsTreatment OutcomeOphthalmic SolutionsFollow-Up StudiesSeverity of Illness IndexLubricant Eye Drops

Stichwörter der Autor:innen

Autologous platelet-rich plasma (aPRP)OSDIautologous serumdry eye diseaseimpression cytology

Substanzen

Ophthalmic SolutionsLubricant Eye Drops

Autor:innen und Institutionen

  • Regional Institute of Ophthalmology, MLN Medical College, Department of Ophthalmology, Prayagraj, India.

ORCID-Profile: Shubhi Sachan, Kshama Dwivedi, Satya Prakash Singh, Santosh Kumar, Vinod Kumar Singh

Zitieren

APA

Sachan, S., Dwivedi, K., Singh, S. P., Kumar, S., & Singh, V. K. (2025). Comparison of 20% Autologous Platelet-Rich Plasma Versus Conventional Treatment in Moderate to Severe Dry Eye Patients. Turkish Journal of Ophthalmology. https://doi.org/10.4274/tjo.galenos.2025.47717

Vancouver

Sachan S, Dwivedi K, Singh SP, Kumar S, Singh VK. Comparison of 20% Autologous Platelet-Rich Plasma Versus Conventional Treatment in Moderate to Severe Dry Eye Patients. Turkish Journal of Ophthalmology. 2025. doi:10.4274/tjo.galenos.2025.47717

BibTeX
@article{Sachan2025,
  author = {Sachan, Shubhi and Dwivedi, Kshama and Singh, Satya Prakash and Kumar, Santosh and Singh, Vinod Kumar},
  title = {Comparison of 20% Autologous Platelet-Rich Plasma Versus Conventional Treatment in Moderate to Severe Dry Eye Patients},
  journal = {Turkish Journal of Ophthalmology},
  year = {2025},
  doi = {10.4274/tjo.galenos.2025.47717}
}
Kostenlos starten →